Pain management startup Sword Health expands into mental health, raises $40 million

Pain management startup Sword Health expands into mental health, raises  million

Sword Health, a startup focused on helping people deal with pain through digital services, is expanding into mental health and has raised additional capital to fuel its growth. The 10-year-old company is introducing Mind, which uses a combination of artificial intelligence, hardware and human mental health professionals to treat patients with mild depression and anxiety. … Read more

Kraft Heinz to remove artificial dyes from U.S. products by end of 2027

Kraft Heinz to remove artificial dyes from U.S. products by end of 2027

Cases of Kool-Aid Jammers are stacked at a Costco Wholesale store on April 27, 2025 in San Diego, California. Kevin Carter | Getty Images Kraft Heinz said Tuesday that it will remove FD&C artificial dyes from its products by the end of 2027, and will not launch any new products in the U.S. containing those … Read more

Anne Wojcicki to buy back 23andMe and its data for $305 million

Anne Wojcicki to buy back 23andMe and its data for 5 million

23andMe founder Anne Wojcicki speaks during a House Committee on Oversight and Government Reform hearing in Washington, D.C., on June 10, 2025. Andrew Harnik | Getty Images Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals, … Read more

Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition

Healthy Returns: Ozempic, Wegovy linked to rare cases of serious eye condition

Weight loss syringes of the brands “Wegovy”, “Ozempic” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. Novo … Read more

What’s next for Oura Ring in personal health and fitness monitoring, according to CEO Tom Hale

What’s next for Oura Ring in personal health and fitness monitoring, according to CEO Tom Hale

When the idea for the Oura Ring was first spawned in 2013, the company’s founders envisioned a device that would take a precise look at sleep and recovery, two important aspects of overall health that they felt few wearable tools had prioritized to that point. Now, over a decade later, Oura’s ambitions have evolved to … Read more

RFK Jr.’s firing of CDC vaccine panel undermines science, could threaten public health, experts say

RFK Jr.’s firing of CDC vaccine panel undermines science, could threaten public health, experts say

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr. leaves the stage after discussing the findings of the Centers for Disease Control and Prevention’s (CDC) latest Autism and Developmental Disabilities Monitoring (ADDM) Network survey, at the Department of Health and Human Services in Washington, D.C., U.S., April 16, 2025. Elizabeth Frantz | Reuters … Read more

RFK Jr. removes all members of CDC panel advising U.S. on vaccines

RFK Jr. removes all members of CDC panel advising U.S. on vaccines

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. testifies before the Senate Committee on Appropriations hearing on the Department of Health and Human Services budget, on Capitol Hill in Washington, D.C., U.S., May 20, 2025. Ken Cedeno | Reuters Health and Human Services Secretary Robert F. Kennedy Jr. on Monday said he … Read more

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

FDA approves Merck’s RSV shot for infants, ramping up competition with Sanofi and AstraZeneca

The Food and Drug Administration on Monday approved Merck’s shot designed to protect infants from respiratory syncytial virus during their first season of the virus, bringing to market a rival to a similar treatment from Sanofi and AstraZeneca. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead … Read more

Omada shares pop 42% in Nasdaq debut after health tech company’s IPO

Omada shares pop 42% in Nasdaq debut after health tech company’s IPO

Omada Health shares jumped more than 40% in their Nasdaq debut Friday after the virtual chronic care company priced its stock at $19 per share in its IPO. The stock opened at $23 and quickly traded past $27. The company said in a press release late Thursday that it sold 7.9 million shares in the … Read more

JPMorgan’s top biotech and pharma picks for the second half

JPMorgan’s top biotech and pharma picks for the second half

Biopharmaceutical stocks’ underperformance versus the broader market for a third-straight year is an opportunity for investors, according to JPMorgan. Analyst Chris Schott said in the firm’s June outlook for biopharma that the sector’s poor performance can be traced back to concerns over President Donald Trump’s tariffs and his ” most favored nation ” executive order. … Read more